FR&D FRESHERS VACANCY IN JODAS EXPOIM PVT LTD @ HYDERABAD

Greetings from Jodas Expoim Pvt Ltd Hyderabad.

We are looking for FR&D Tr. Research Associates

Qualification Require:
M.Pharm (Pharmaceutics)/ M.Pharm ( Industrial Pharmacy)/ M.Pharm (Pharmacology).

Passed out in 2016 is mandatory.

Interested candidates may send their profiles to planthr@jodasexpoim.in

For more information please contact to 9100953911

For more updates follow srinivasulutirumalasetty.blogspot.com

Thank you for visiting my blog , Visit again for latest pharma updates

URGENT MULTIPLE VACANCY IN BIOPHORE INDIA PHARMACEUTICALS @ HYDERABAD

Hi all,

Biophore India Pharmaceuticals hyderabad based company  is looking for urgent requirments of

API  process R&D Exp 2-7 years of experience - 60 positions

Analytical R&D or QC back ground with HPLC handling exp -20 positions for API &Formulation

Purchase executive / sr.executive level with 3 to 6 of pharma experience - 2 positions

API Project management with 2- 5 years of experience - 2positions

Formulation Packaging & Development 2 to 4 years of experience

Interested candidates please send your updated resume to sravan@biophore.com

For more updates follow srinivasulutirumalasetty.blogspot.com

Thank you for visiting my blog , Visit again for latest pharma updates

Lupin receives US FDA approval for Novartis generic

Tobramycin inhalation solution USP, 300 mg/5 ml, had sales of $133.6 million in the US as of December 2016, Lupin stated in a release about the development.

NEW DELHI: The United States Food and Drug Administration (US FDA) has granted Indian drug maker Lupin final approval to market a generic version of Swiss pharmaceutical giant Novartis’tobramycin inhalation solution‘Tobi’.

The drug is used to treat cystic fibrosis patients with P. aeruginosa.

Tobramycin inhalation solution USP, 300 mg/5 ml, had sales of $133.6 million in the US as of December 2016, Lupin stated in a release about the development.

Share prices of Lupin rose 1.58 per cent to close at Rs1,490 on the Bombay Stock Exchange on Thursday, while the benchmark Sensex ended 0.56 per cent higher.

Source : http://health.economictimes.indiatimes.com/news/pharma/lupin-receives-us-fda-approval-for-novartis-generic/57793282

For more updates follow srinivasulutirumalasetty.blogspot.com

Thank you for visiting my blog , Visit again for latest pharma updates